Investors

CENTERLINE BIOMEDICAL OVERVIEW

About

Centerline Biomedical is a Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS™) technology — an innovative, 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure.

HISTORY

Founded at Cleveland Clinic following the vision of renowned vascular surgeon, Roy Greenberg, MD

PROBLEM

Radiation emitting, 2D grayscale fluoroscopy has remained mainly unchanged decades

SOLUTION

IOPS™ (Intra-Operative Positioning System) 3D surgical navigation platform technology

TEAM

Well experienced leadership team averaging 20+ years in healthcare

ADVISORY BOARD

Scientific advisory board: Matthew Eagleton, MD (Mass General), Robert Beasley, MD (Mt. Siai), Mark Farber, MD (UNC Hospitals), Gustavo Oderich, MD (UTHealth & Memorial Hermann), Federicon Ezequiel Parodi, MD (UNC Hospitals), Rishi Puri, MD (Cleveland Clinic), Peter Rasmussen, MD, FAHA, FAANS, FSNIS (Cleveland Clinic), Karl West, MS (Cleveland Clinic)

HIGHLIGHTS

Z

FDA Cleared

510(k) approved in a large market ($3.1B) for procedures in the descending aorta

R&D Pipeline

– Structural Heart (TAVR, TP, TMVR)
– Peripheral Vascular Disease
– Vascular Surgery

Intellectual Property

Rich and growing IP portfolio with 17 issued and 37 pending patents

A

Strategic Partnerships

Two signed, two in advanced stages. Broad range of partnership opportunities.

Clinical

First in Human procedures completed

GeoEx

Expanding to Europe & beyond in 2021

Commercial

Controlled launch ongoing

h

Grants

Recipient of 4 NIH Grants

CONTACT & LEARN MORE